flagyl leggangastíll 500 mg
sanofi-aventis norge as - metronidazolum inn - leggangastíll - 500 mg
pevaryl krem + leggangastíll (10 mg/g + 150 mg)
trimb healthcare ab - econazolum nítrat; econazolum nítrat - krem + leggangastíll - (10 mg/g + 150 mg)
pevaryl depot krem + leggangastíll (1% + 150 mg)
trimb healthcare ab - econazolum nítrat; econazolum nítrat - krem + leggangastíll - (1% + 150 mg)
pevaryl depot leggangastíll 150 mg
trimb healthcare ab - econazolum nítrat - leggangastíll - 150 mg
canesten leggangatafla 100 mg
bayer ab - clotrimazolum inn - leggangatafla - 100 mg
canesten leggangatafla 500 mg
bayer ab - clotrimazolum inn - leggangatafla - 500 mg
teysuno
nordic group b.v. - tegafúri, gimeracil, oteracil - magaæxli - Æxlishemjandi lyf - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg
prograf hart hylki 5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg